Sab Biotherapeutics Inc. (SABS)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 54
-0.12
-3.4106%
$
34.41M Market Cap
0.1 P/E Ratio
- Div Yield
678,400 Volume
0 Eps
$ 3.67
Previous Close 
Want to track SABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sab Biotherapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 50 | $227 | $181.25 | -$45.75 | -20.15% |
| RF Rekah Franca Catalyst Funds Management Pty Ltd. | 15,100 | $57,833 | $54,737.5 | -$3,095.5 | -5.35% |
| WTM W. Travis McKinney HB Wealth Management LLC | 307,500 | $618,075 | $1.08M | $464,325 | 75.12% |
 Kevin Roan Stempoint Capita LLP | 375,000 | $1.42M | $1.35M | -$71,184.85 | -5% |
| HFT Hui Fai Tam Caitong International Asset Management Co. Ltd. | 161 | $617 | $575.57 | -$41.43 | -6.71% |
 Jim Harding Propel Bio Management LLC | 1.01M | $3.82M | $3.65M | -$176,843.89 | -4.63% |
| RJ Rebecca Judd Pathstone Holdings, LLC | 50,650 | $229,953 | $183,859.5 | -$46,093.5 | -20.04% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 69,732 | $265,293.17 | $252,778.5 | -$12,514.67 | -4.72% |
